ARMEN GARO H 13D and 13G filings for MiNK Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 6:05 pm Purchase | 2024-01-16 | 13D | MiNK Therapeutics, Inc. INKT | ARMEN GARO H | 351,432 9.680% | 89,744 (+34.29%) | Filing |
| 2022-02-14 4:06 pm Purchase | 2021-12-31 | 13G | MiNK Therapeutics, Inc. INKT | ARMEN GARO H | 261,688 7.820% | 261,688 (New Position) | Filing |